Ya-Jun Yang Selected Research

aspirin eugenol ester

1/2020	Aspirin Eugenol Ester Protects Vascular Endothelium From Oxidative Injury by the Apoptosis Signal Regulating Kinase-1 Pathway.
6/2019	Aspirin eugenol ester inhibits agonist-induced platelet aggregation in vitro by regulating PI3K/Akt, MAPK and Sirt 1/CD40L pathways.
12/2018	Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia.
10/2017	UPLC-Q-TOF/MS-based urine and plasma metabonomics study on the ameliorative effects of aspirin eugenol ester in hyperlipidemia rats.
1/2017	Impact of Aspirin Eugenol Ester on Cyclooxygenase-1, Cyclooxygenase-2, C-Reactive Protein, Prothrombin and Arachidonate 5-Lipoxygenase in Healthy Rats.
8/2015	Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia.
1/2015	Preventive Effect of Aspirin Eugenol Ester on Thrombosis in κ-Carrageenan-Induced Rat Tail Thrombosis Model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ya-Jun Yang Research Topics

Disease

12	Neoplasms (Cancer) 02/2019 - 01/2012
7	Inflammation (Inflammations) 06/2019 - 01/2015
6	Stomach Neoplasms (Stomach Cancer) 12/2016 - 07/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 08/2015
3	Muscular Atrophy (Muscle Atrophy) 06/2022 - 04/2014
3	Pain (Aches) 06/2019 - 08/2015
3	Fever (Fevers) 06/2019 - 08/2015
3	Hyperlipidemias (Hyperlipidemia) 12/2018 - 08/2015
3	Thrombosis (Thrombus) 01/2017 - 01/2015
2	Developmental Bone Diseases (Bone Dysplasia) 01/2019 - 01/2019
2	Infections 01/2019 - 09/2016
2	Breast Neoplasms (Breast Cancer) 09/2017 - 12/2014
2	Carcinogenesis 03/2017 - 12/2016
2	Body Weight (Weight, Body) 11/2016 - 03/2013
2	Chronic Renal Insufficiency 05/2015 - 01/2015
2	Atrophy 01/2015 - 04/2014
2	Esophageal Squamous Cell Carcinoma 06/2013 - 01/2012
1	Intestinal Diseases (Diseases, Intestinal) 01/2022
1	Acute Lung Injury 01/2021
1	Lung Injury 01/2021
1	Neuroblastoma 01/2021
1	Foot and Mouth Disease Hand (Hand, Foot, Mouth Disease) 12/2020
1	Necrosis 01/2019
1	Albinism 01/2019
1	Osteomyelitis 01/2019
1	Osteoporosis 04/2018
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2018
1	Diarrhea 01/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017
1	Prehypertension 12/2016
1	Hypertension (High Blood Pressure) 12/2016
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2015
1	Fibrosis (Cirrhosis) 05/2015

Drug/Important Bio-Agent (IBA)

7	aspirin eugenol esterIBA 01/2020 - 01/2015
7	Proteins (Proteins, Gene)FDA Link 06/2018 - 01/2012
6	Pharmaceutical PreparationsIBA 01/2020 - 01/2013
3	Complement System Proteins (Complement)IBA 06/2018 - 12/2014
2	ResveratrolIBA 06/2022 - 04/2014
2	Caffeine (No Doz)FDA LinkGeneric 01/2019 - 09/2016
2	Biological ProductsIBA 01/2019 - 05/2015
2	CD55 Antigens (Decay Accelerating Factor)IBA 06/2018 - 09/2017
2	GlucocorticoidsIBA 04/2018 - 04/2014
2	Trastuzumab (Herceptin)FDA Link 09/2017 - 12/2014
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2017 - 08/2015
2	EugenolIBA 01/2017 - 08/2015
2	ORALIT (ORS)IBA 12/2016 - 01/2012
2	Simvastatin (Zocor)FDA LinkGeneric 11/2016 - 08/2015
2	CarrageenanIBA 06/2016 - 01/2015
2	TOR Serine-Threonine KinasesIBA 11/2015 - 11/2013
2	UbiquitinIBA 01/2015 - 04/2014
2	Mechanistic Target of Rapamycin Complex 1IBA 11/2013 - 06/2013
2	MicroRNAs (MicroRNA)IBA 01/2013 - 01/2013
1	naringeninIBA 01/2022
1	Analgesics (Analgesic Drugs)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	AntipyreticsIBA 01/2022
1	ParaquatIBA 01/2021
1	Therapeutic UsesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 12/2020
1	SiliconIBA 02/2019
1	CytokinesIBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	theanineIBA 01/2019
1	Vancomycin FDA LinkGeneric 01/2019
1	AntigensIBA 06/2018
1	CD59 AntigensIBA 06/2018
1	Heterophile AntigensIBA 06/2018
1	PolyphenolsIBA 04/2018
1	tanshinolIBA 04/2018
1	VaccinesIBA 01/2018
1	pyrimidineIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 10/2017
1	Amino Acids FDA Link 10/2017
1	SphingolipidsIBA 10/2017
1	Glycerophospholipids (Phosphoglycerides)IBA 10/2017
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2017
1	human ERBB2 proteinIBA 09/2017
1	Glycoproteins (Glycoprotein)IBA 09/2017
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA 01/2017
1	Prothrombin (Factor II)IBA 01/2017
1	Cyclooxygenase 1IBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 12/2016
1	low density lipoprotein inhibitorIBA 11/2016
1	Interleukin-6 (Interleukin 6)IBA 05/2016
1	CholesterolIBA 08/2015
1	Triglycerides (Triacylglycerol)IBA 08/2015
1	HDL LipoproteinsIBA 08/2015
1	LipidsIBA 08/2015
1	LDL Lipoproteins (beta Lipoproteins)IBA 08/2015
1	oxidized low density lipoproteinIBA 08/2015
1	tanshinoneIBA 05/2015
1	Hemoglobins (Hemoglobin)IBA 01/2015
1	MyostatinIBA 01/2015

Therapy/Procedure

2	Therapeutics 06/2018 - 12/2014
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2017 - 05/2015
1	Debridement 01/2019
1	Oral Administration 06/2016